Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufeng Ding

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|May 6, 2022
Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in ChinaYamin Shu, Yufeng Ding, Qilin Zhang
Sexual Medicine Reviews|January 26, 2020
Current Status and Prospects in the Treatment of Erectile Dysfunction by Adipose-Derived Stem Cells in the Diabetic Animal ModelHao Yan, Yufeng Ding, Mujun Lu
BMC Health Services Research|December 31, 2018
The availability, price and affordability of essential antibacterials in Hubei province, ChinaGuangjie Wu, Shiwei Gong, Hongbing Cai, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
Development and validation for the quantitative determination of xanthine oxidoreductase inhibitor topiroxostat by LC-MS/MS and its clinico-pharmacokinetic studyXiangling Feng, Yan Cao, Yufeng Ding, et al.
International Immunopharmacology|July 5, 2023
Cost-effectiveness of nivolumab versus sorafenib as first-line treatment for advanced hepatocellular carcinomaYamin Shu, Ying Tang, Yufeng Ding, et al.
Journal of Ethnopharmacology|May 13, 2022
Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in ratsXiangling Feng, Youquan Shi, Yufeng Ding, et al.
Acta Biochimica Et Biophysica Sinica|October 9, 2010
Asc1, a WD-repeat protein, is required for hyphal development and virulence in Candida albicansXiaoyan Liu, Xinyi Nie, Yufeng Ding, et al.
Expert Opinion on Drug Safety|December 17, 2021
A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting systemYamin Shu, Yufeng Ding, Bing Dai, et al.
Frontiers in Medicine|July 17, 2025
Bridging tradition and innovation: a constitution-guided framework for personalized blood pressure management in acute ischemic strokeXuran Zhang, Kegang Cao, Li Zhou, et al.
Frontiers in Pharmacology|August 29, 2022
Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in chinaYamin Shu, Yanxin Liu, Xucheng He, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|May 6, 2022
Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in ChinaYamin Shu, Yufeng Ding, Qilin Zhang
Sexual Medicine Reviews|January 26, 2020
Current Status and Prospects in the Treatment of Erectile Dysfunction by Adipose-Derived Stem Cells in the Diabetic Animal ModelHao Yan, Yufeng Ding, Mujun Lu
BMC Health Services Research|December 31, 2018
The availability, price and affordability of essential antibacterials in Hubei province, ChinaGuangjie Wu, Shiwei Gong, Hongbing Cai, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 16, 2020
Development and validation for the quantitative determination of xanthine oxidoreductase inhibitor topiroxostat by LC-MS/MS and its clinico-pharmacokinetic studyXiangling Feng, Yan Cao, Yufeng Ding, et al.
International Immunopharmacology|July 5, 2023
Cost-effectiveness of nivolumab versus sorafenib as first-line treatment for advanced hepatocellular carcinomaYamin Shu, Ying Tang, Yufeng Ding, et al.
Journal of Ethnopharmacology|May 13, 2022
Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in ratsXiangling Feng, Youquan Shi, Yufeng Ding, et al.
Acta Biochimica Et Biophysica Sinica|October 9, 2010
Asc1, a WD-repeat protein, is required for hyphal development and virulence in Candida albicansXiaoyan Liu, Xinyi Nie, Yufeng Ding, et al.
Expert Opinion on Drug Safety|December 17, 2021
A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting systemYamin Shu, Yufeng Ding, Bing Dai, et al.
Frontiers in Medicine|July 17, 2025
Bridging tradition and innovation: a constitution-guided framework for personalized blood pressure management in acute ischemic strokeXuran Zhang, Kegang Cao, Li Zhou, et al.
Frontiers in Pharmacology|August 29, 2022
Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in chinaYamin Shu, Yanxin Liu, Xucheng He, et al.
Pageof 7